X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4664) 4664
Publication (821) 821
Book Review (56) 56
Book Chapter (31) 31
Dissertation (15) 15
Conference Proceeding (10) 10
Government Document (3) 3
Magazine Article (2) 2
Book / eBook (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2744) 2744
indoleamine 2,3-dioxygenase (2742) 2742
humans (2494) 2494
animals (2047) 2047
immunology (1404) 1404
dendritic cells (1163) 1163
female (1140) 1140
tryptophan (1140) 1140
mice (1086) 1086
indoleamine-pyrrole 2,3,-dioxygenase - metabolism (1081) 1081
male (1062) 1062
tryptophan catabolism (684) 684
inflammation (658) 658
interferon-gamma (651) 651
expression (650) 650
cancer (630) 630
tryptophan - metabolism (614) 614
regulatory t-cells (593) 593
indoleamine-pyrrole 2,3,-dioxygenase - genetics (550) 550
t cells (544) 544
immunotherapy (541) 541
biochemistry & molecular biology (536) 536
oncology (512) 512
neurosciences (508) 508
cell biology (490) 490
enzymes (482) 482
adult (474) 474
middle aged (471) 471
ido (465) 465
analysis (461) 461
cells, cultured (453) 453
article (449) 449
research (434) 434
tolerance (426) 426
dendritic cells - immunology (424) 424
inhibition (415) 415
physiological aspects (413) 413
mice, inbred c57bl (409) 409
kynurenine (404) 404
t-cells (382) 382
cytokines (380) 380
indoleamine 2 (371) 371
kynurenine - metabolism (369) 369
t-lymphocytes, regulatory - immunology (345) 345
medicine, research & experimental (344) 344
metabolism (341) 341
3-dioxygenase (335) 335
health aspects (334) 334
ifn-gamma (333) 333
indoleamine-pyrrole 2,3,-dioxygenase - antagonists & inhibitors (325) 325
metabolites (325) 325
in-vivo (316) 316
gene expression (313) 313
quinolinic acid (312) 312
immunosuppression (303) 303
t-lymphocytes - immunology (299) 299
pharmacology & pharmacy (297) 297
lymphocytes (296) 296
indoleamine-pyrrole 2,3,-dioxygenase - immunology (292) 292
rats (290) 290
kynurenine pathway (289) 289
aged (286) 286
activation (283) 283
immune tolerance (282) 282
induction (279) 279
tryptophan 2,3-dioxygenase (278) 278
transplantation (271) 271
immune system (268) 268
cell proliferation (262) 262
hematology (255) 255
immune response (255) 255
indoleamine-pyrrole 2,3,-dioxygenase (248) 248
apoptosis (238) 238
tumors (238) 238
care and treatment (237) 237
research article (236) 236
disease models, animal (232) 232
pregnancy (230) 230
cells (226) 226
serotonin (226) 226
interferon (223) 223
lymphocytes t (223) 223
mice, inbred balb c (220) 220
brain (218) 218
immunohistochemistry (216) 216
signal transduction (216) 216
interferon-gamma - pharmacology (214) 214
tryptophan oxygenase - metabolism (211) 211
mice, knockout (207) 207
depression (205) 205
cell line, tumor (204) 204
multidisciplinary sciences (203) 203
stem cells (203) 203
medicine (202) 202
tryptophan - blood (202) 202
cytokines - metabolism (200) 200
immunomodulation (200) 200
aryl-hydrocarbon receptor (196) 196
macrophages (196) 196
psychiatry (194) 194
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4638) 4638
Chinese (24) 24
Japanese (14) 14
Korean (8) 8
Portuguese (4) 4
Russian (3) 3
German (2) 2
Czech (1) 1
French (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic Oncology, ISSN 0090-8258, 09/2017, Volume 146, Issue 3, pp. 484 - 490
Indoleamine 2,3-dioxygenase-1 (IDO1) is a key regulator of immune tolerance in ovarian cancer. This study investigated efficacy and safety of the IDO1 enzyme... 
Epacadostat | IDO1 enzyme inhibitor | Tamoxifen | Ca-125 | Ovarian cancer | SURVIVAL | DIAGNOSIS | PROTEIN | PROGNOSIS | INDOLEAMINE 2,3-DIOXYGENASE | OBSTETRICS & GYNECOLOGY | ONCOLOGY | IMMUNOTHERAPY | EXPRESSION | T-CELLS | Recurrence | Neoplasms, Glandular and Epithelial - chemistry | Oximes - pharmacokinetics | Oximes - adverse effects | Peritoneal Neoplasms - blood | Humans | Middle Aged | Oximes - therapeutic use | Response Evaluation Criteria in Solid Tumors | Fatigue - chemically induced | Peritoneal Neoplasms - chemistry | Antineoplastic Agents, Hormonal - adverse effects | Early Termination of Clinical Trials | Fallopian Tube Neoplasms - blood | Neoplasms, Glandular and Epithelial - blood | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - chemistry | Exanthema - chemically induced | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Ovarian Neoplasms - drug therapy | Pruritus - chemically induced | Fallopian Tube Neoplasms - drug therapy | Drug Eruptions - etiology | Ovarian Neoplasms - chemistry | CA-125 Antigen - blood | Indoleamine-Pyrrole 2,3,-Dioxygenase - analysis | Ovarian Neoplasms - blood | Survival Rate | Sulfonamides - pharmacokinetics | Disease-Free Survival | Sulfonamides - therapeutic use | Tamoxifen - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Sulfonamides - adverse effects | Aged | Tamoxifen - adverse effects | Indoleamine-Pyrrole 2,3,-Dioxygenase - antagonists & inhibitors | Care and treatment | Chemotherapy | Enzyme inhibitors | Cancer | Medical research | Medicine, Experimental
Journal Article
Immunology, ISSN 0019-2805, 10/2015, Volume 146, Issue 2, pp. 292 - 300
Summary Indoleamine 2,3‐dioxygenase (IDO) is expressed in antigen‐presenting cells and exerts immunosuppressive effects on CD4+ T cells. One mechanism is... 
fatty acid | indoleamine 2,3‐dioxygenase | general control non‐derepressible 2 kinase | acetyl coenzyme A carboxylase 1 | T cells | ATP‐citrate lyase | Indoleamine 2,3-dioxygenase | Acetyl coenzyme A carboxylase 1 | Fatty acid | ATP-citrate lyase | General control non-derepressible 2 kinase | SURVIVAL | GCN2 | TOLERANCE | INDUCTION | IMMUNOLOGY | GLYCOLYSIS | AMINO-ACID | INHIBITION | METABOLISM | ARYL-HYDROCARBON RECEPTOR | general control non-derepressible 2 kinase | indoleamine 2,3-dioxygenase | EXPRESSION | Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism | Cell Proliferation | Signal Transduction | TOR Serine-Threonine Kinases - metabolism | Lymphocyte Activation | Down-Regulation | Humans | Cells, Cultured | CD4-Positive T-Lymphocytes - enzymology | Lymphocyte Culture Test, Mixed | Mechanistic Target of Rapamycin Complex 1 | CD4-Positive T-Lymphocytes - immunology | Gene Expression Regulation, Enzymologic | Multiprotein Complexes - metabolism | Tryptophan - deficiency | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Differentiation | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | CD4-Positive T-Lymphocytes - drug effects | Indoleamine-Pyrrole 2,3,-Dioxygenase - antagonists & inhibitors | Protein-Serine-Threonine Kinases - metabolism | Fatty Acids - biosynthesis | Enzymes | Cell growth | T cell receptors | Dehydrogenases | Kinases | Lymphocytes | Original
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2015, Volume 10, Issue 2, pp. e0118562 - e0118562
Dendritic cells (DC) interact with naive T cells to regulate the delicate balance between immunity and tolerance required to maintain immunological... 
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | IN-VITRO | NOD MICE | INHIBITION | ARYL-HYDROCARBON RECEPTOR | NONOBESE DIABETIC MICE | IMMUNE-RESPONSES | MULTIDISCIPLINARY SCIENCES | REGULATORY T-CELLS | 2,3-DIOXYGENASE | TRYPTOPHAN CATABOLISM | Indoleamine-Pyrrole 2,3,-Dioxygenase - biosynthesis | Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics | Signal Transduction | Monocytes - cytology | Vaccines, Subunit - genetics | Dendritic Cells - immunology | Humans | Monocytes - metabolism | NF-kappa B - metabolism | Proinsulin - genetics | Proteome | Gene Expression Profiling | Vaccines, Subunit - immunology | Cholera Toxin - genetics | Proteomics | Cholera Toxin - immunology | Cell Differentiation | Dendritic Cells - cytology | Dendritic Cells - metabolism | Cluster Analysis | Proinsulin - immunology | Autoimmunity | Enzymes | Dendritic cells | Type 1 diabetes | Vaccination | Physiological aspects | Tryptophan | Protein biosynthesis | Cholera | Vaccines | Cholera toxin | T cells | Disease | Mucosa | Bar codes | Hydrocarbons | Biochemistry | Immunity | Proteins | Hyperglycemia | Inhibition | Fusion protein | Public health | Cholera toxin B subunit | NF-κB protein | Dioxygenase | Antigens | Cytokines | Toxin b | Insulin | Immunological tolerance | Immunosuppression | Protein synthesis | Water-borne diseases | Homeostasis | Lymphocytes T | Diabetes mellitus (insulin dependent) | Infections | Biosynthesis | Kinases | Inoculation | Immunology | Lymphocytes | Pancreas | Immune system | Degradation products | Maturation | Therapeutic applications | Diabetes mellitus | Inflammation | Pharmacology | Medicine | Monocytes | Diabetes | Autoimmune diseases | Dendritic structure | Health disparities | Index Medicus
Journal Article
Microbiology and Immunology, ISSN 0385-5600, 02/2018, Volume 62, Issue 2, pp. 71 - 79
Journal Article